These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 2413299
21. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Mizumura T, Nithipatikom K, Gross GJ. Circulation; 1995 Sep 01; 92(5):1236-45. PubMed ID: 7648671 [Abstract] [Full Text] [Related]
22. Intravenous aspirin at reperfusion does not reduce infarct size in the dog with a residual critical stenosis. Libersan D, Quan E, Merhi Y, Uzan A, Laperrière L, Latour JG. J Cardiovasc Pharmacol; 1999 Oct 01; 34(4):575-83. PubMed ID: 10511134 [Abstract] [Full Text] [Related]
23. Protective effects of N-2-mercaptopropionyl glycine against myocardial reperfusion injury after neutrophil depletion in the dog: evidence for the role of intracellular-derived free radicals. Mitsos SE, Askew TE, Fantone JC, Kunkel SL, Abrams GD, Schork A, Lucchesi BR. Circulation; 1986 May 01; 73(5):1077-86. PubMed ID: 3698230 [Abstract] [Full Text] [Related]
24. Cardiac and vascular imaging with labeled platelets and leukocytes. Dewanjee MK. Semin Nucl Med; 1984 Jul 01; 14(3):154-87. PubMed ID: 6382615 [Abstract] [Full Text] [Related]
29. Myeloperoxidase activity as a quantitative marker of polymorphonuclear leukocyte accumulation into an experimental myocardial infarct--the effect of ibuprofen on infarct size and polymorphonuclear leukocyte accumulation. Allan G, Bhattacherjee P, Brook CD, Read NG, Parke AJ. J Cardiovasc Pharmacol; 1985 Nov 01; 7(6):1154-60. PubMed ID: 2418303 [Abstract] [Full Text] [Related]
30. The role of serotonin (5HT2) receptor blockade in myocardial reperfusion injury: effects of LY53857 in a canine model of myocardial infarction. Simpson PJ, Schelm JA, Jakubowski JA, Smallwood JK. J Pharmacol Exp Ther; 1991 Sep 01; 258(3):979-85. PubMed ID: 1653847 [Abstract] [Full Text] [Related]
31. Thromboxane synthetase inhibitors reduce infarct size by a platelet-dependent, aspirin-sensitive mechanism. Mullane KM, Fornabaio D. Circ Res; 1988 Apr 01; 62(4):668-78. PubMed ID: 3127073 [Abstract] [Full Text] [Related]
33. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion. Forman MB, Pitarys CJ, Vildibill HD, Lambert TL, Ingram DA, Virmani R, Murray JJ. J Am Coll Cardiol; 1992 Jan 01; 19(1):205-16. PubMed ID: 1729335 [Abstract] [Full Text] [Related]